Will an activist investor campaign against Pfizer lead to big changes at the struggling Pharma giant? Why are some experts questioning the regulatory standards used to approve gene therapies for Duchenne muscular dystrophy? What’s the difference between Novo Holdings and Novo Nordisk, and will it impact a $16 billion acquisition of Catalent? And what lies ahead for Robert F. Kennedy Jr. and the Make America Healthy Again movement?
資訊
- 節目
- 頻率每週更新
- 發佈時間2024年10月24日 下午6:02 [UTC]
- 長度34 分鐘
- 年齡分級兒少適宜